The lung: The natural boundary between nature and nurture

Annual Review of Physiology

Volumn 73, Issue , 2011, Pages 457-478

  Seibold, Max A ^a   Schwartz, David A ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

asthma; COPD; epigenetics; genetic admixture; pulmonary fibrosis; rare variant genetics

Indexed keywords

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENVIRONMENTAL IMPACT; EPIGENETICS; GENE INTERACTION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; KNOWLEDGE; LUNG DISEASE; MEDICAL TECHNOLOGY; MOLECULAR CLONING; NATURAL SCIENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ASTHMA; ENVIRONMENTAL POLLUTANTS; EPIGENOMICS; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG; MALE; MICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS;

EID: 79951796396     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-012110-142212     Document Type: Article

References (133)

1. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, DubinW. 1999. Bacterial endotoxin is an active component of cigarette smoke. Chest 115:829-35 (Pubitemid 29129968)
2. Reed CE, Milton DK. 2001. Endotoxin-stimulated innate immunity: a contributing factor for asthma. J. Allergy Clin. Immunol. 108:157-66 (Pubitemid 32735395)
3. Cochran JR, Khan AM, Elidemir O, XueH, Cua B, et al. 2002. Influence of lipopolysaccharide exposure on airway function and allergic responses in developing mice. Pediatr. Pulmonol. 34:267-77
4. O'Grady NP, Preas HL, Pugin J, Fiuza C, Tropea M, et al. 2001. Local inflammatory responses following bronchial endotoxin instillation in humans. Am. J. Respir. Crit. CareMed. 163:1591-98 (Pubitemid 32578761)
5. Singh J, Schwartz DA. 2005. Endotoxin and the lung: insight into the host-environment interaction. J. Allergy Clin. Immunol. 115:330-33 (Pubitemid 40215098)
6. Domenici L, Pieri L, Galle MB, Romagnoli P, Adembri C. 2004. Evolution of endotoxin-induced lung injury in the rat beyond the acute phase. Pathobiology 71:59-69 (Pubitemid 38056725)
7. Vernooy JH, DentenerMA, van Suylen RJ, BuurmanWA, Wouters EF. 2002. Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am. J. Respir. Cell Mol. Biol. 26:152-59 (Pubitemid 34029832)
8. Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, et al. 2002. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 347:869-77
9. Akinbami LJ, Schoendorf KC. 2002. Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 110:315-22 (Pubitemid 34833016)
10. Bouzigon E, Corda E, Aschard H, DizierMH, Boland A, et al. 2008. Effect of 17q21 variants and smoking exposure in early-onset asthma. N. Engl. J. Med. 359:1985-94
11. von Mutius E. 2009. Gene-environment interactions in asthma. J. Allergy Clin. Immunol. 123:3-11
12. Jerrett M, Shankardass K, Berhane K, Gauderman WJ, Kunzli N, et al. 2008. Traffic-related air pollution and asthma onset in children: a prospective cohort study with individual exposuremeasurement. Environ. Health Perspect. 116:1433-38
13. Gauderman WJ, Vora H, McConnell R, Berhane K, Gilliland F, et al. 2007. Effect of exposure to traffic on lung development from 10 to 18 years of age: a cohort study. Lancet 369:571-77
14. Garantziotis S, Schwartz DA. Ecogenomics of respiratory diseases of public health significance. Annu. Rev. Public Health 31:37-51
15. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. 2005. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann. Intern. Med. 142:233-39 (Pubitemid 40216240)
16. Baumgartner KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, et al. 2000. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. Am. J. Epidemiol. 152:307-15 (Pubitemid 30626724)
17. Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. 1997. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am. J. Respir. Crit. CareMed. 155:242-48 (Pubitemid 27053171)
18. Hubbard R, Lewis S, Richards K, Johnston I, Britton J. 1996. Occupational exposure to metal or wood dust and etiology of cryptogenic fibrosing alveolitis. Lancet 347:284-89 (Pubitemid 26041039)
19. Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y. 1994. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am. J. Respir. Crit. CareMed. 150:670-75 (Pubitemid 24291493)
20. Rosas IO, Ren P, Avila NA, Chow CK, Franks TJ, et al. 2007. Early interstitial lung disease in familial pulmonary fibrosis. Am. J. Respir. Crit. Care. Med. 176:698-705 (Pubitemid 47503078)
21. Steele MP, Speer MC, Loyd JE, Brown KK, Herron A, et al. 2005. Clinical and pathologic features of familial interstitial pneumonia. Am. J. Respir. Crit. CareMed. 172:1146-52 (Pubitemid 43066651)
22. Taskar VS, Coultas DB. 2006. Is idiopathic pulmonary fibrosis an environmental disease? Proc. Am. Thorac. Soc. 3:293-98 (Pubitemid 43845405)
23. Brody AR. 1993. Asbestos-induced lung disease. Environ. Health Perspect. 100:21-30 (Pubitemid 23197089)
24. O'Reilly KM, McLaughlin AM, Beckett WS, Sime PJ. 2007. Asbestos-related lung disease. Am. Fam. Physician 75:683-88
25. Sanchez VC, Pietruska JR, Miselis NR, Hurt RH, Kane AB. 2009. Biopersistence and potential adverse health impacts of fibrous nanomaterials: What have we learned from asbestos? Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1:511-29
26. Kamp DW. 2009. Asbestos-induced lung diseases: an update. Transl. Res. 153:143-52
27. Liu G, Beri R, Mueller A, Kamp DW. 2010. Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis. Chem. Biol. Interact. 188:309-18
28. Yao S, DellaVentura G, Petibois C. 2010. Analytical characterization of cell-asbestos fiber interactions in lung pathogenesis. Anal. Bioanal. Chem. 397:2079-89
29. Panduri V, Surapureddi S, Soberanes S, Weitzman SA, Chandel N, Kamp DW. 2006. P53 mediates amosite asbestos-induced alveolar epithelial cell mitochondria-regulated apoptosis. Am. J. Respir. Cell Mol. Biol. 34:443-52
30. Fitzsimon N, Fallon U, O'Mahony D, Loftus BG, Bury G, et al. 2007. Mothers' dietary patterns during pregnancy and risk of asthma symptoms in children at 3 years. Ir. Med. J. 100:S27-32
31. Haberg SE, London SJ, Stigum H, Nafstad P, Nystad W. 2009. Folic acid supplements in pregnancy and early childhood respiratory health. Arch. Dis. Child 94:180-84
32. Hollingsworth JW, Maruoka S, Boon K, Garantziotis S, Li Z, et al. 2008. In utero supplementation with methyl donors enhances allergic airway disease in mice. J. Clin. Investig. 118:3462-69
33. Astemborski JA, Beaty TH, Cohen BH. 1985. Variance components analysis of forced expiration in families. Am. J. Med. Genet. 21:741-53 (Pubitemid 15237657)
34. Lewitter FI, Tager IB, McGue M, Tishler PV, Speizer FE. 1984. Genetic and environmental determinants of level of pulmonary function. Am. J. Epidemiol. 120:518-30 (Pubitemid 14041859)
35. Hopper JL, HannahMC, Macaskill GT, Mathews JD. 1990. Twin concordance for a binary trait. III. A bivariate analysis of hay fever and asthma. Genet. Epidemiol. 7:277-89 (Pubitemid 20344963)
36. Nieminen MM, Kaprio J, Koskenvuo M. 1991. A population-based study of bronchial asthma in adult twin pairs. Chest 100:70-75
37. Barnes PJ. 1999. Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease. Thorax 54:245-52 (Pubitemid 29110506)
38. Silverman EK, Speizer FE. 1996. Risk factors for the development of chronic obstructive pulmonary disease. Med. Clin. N. Am. 80:501-22 (Pubitemid 26146094)
39. Bonanni PP, Frymoyer JW, Jacox RF. 1965. A family study of idiopathic pulmonary fibrosis. A possible dysproteinemic and genetically determined disease. Am. J. Med. 39:411-21
40. Javaheri S, LedererDH, Pella JA, Mark GJ, Levine BW. 1980. Idiopathic pulmonary fibrosis inmonozygotic twins. The importance of genetic predisposition. Chest 78:591-94 (Pubitemid 10005877)
41. Solliday NH, Williams JA, Gaensler EA, Coutu RE, Carrington CB. 1973. Familial chronic interstitial pneumonia. Am. Rev. Respir. Dis. 108:193-204
42. Swaye P, Van Ordstrand HS, McCormack LJ, Wolpaw SE. 1969. Familial Hamman-Rich syndrome. Report of eight cases. Dis. Chest 55:7-12
43. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. 1994. The epidemiology of interstitial lung diseases. Am. J. Respir. Crit. CareMed. 150:967-72 (Pubitemid 24318021)
44. Ortiz LA, Lasky J, Hamilton RF Jr, Holian A, Hoyle GW, et al. 1998. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Exp. Lung Res. 24:721-43 (Pubitemid 28533206)
45. Polakoff PL, Horn BR, Scherer OR. 1979. Prevalence of radiographic abnormalities among Northern California shipyard workers. Ann. N. Y. Acad. Sci. 330:333-39 (Pubitemid 11223567)
46. Rossi GA, Szapiel S, Ferrans VJ, Crystal RG. 1987. Susceptibility to experimental interstitial lung disease is modified by immune- and nonimmune-related genes. Am. Rev. Respir. Dis. 135:448-55 (Pubitemid 17012112)
47. Selikoff IJ, Lilis R, Nicholson WJ. 1979. Asbestos disease in United States shipyards. Ann. N. Y. Acad. Sci. 330:295-311 (Pubitemid 11223563)
48. Riccardi VM. 1981. Von Recklinghausen neurofibromatosis. N. Engl. J. Med. 305:1617-27
49. Terry RD, Sperry WM, Brodoff B. 1954. Adult lipidosis resembling Niemann-Pick's disease. Am. J. Pathol. 30:263-85
50. DePinho RA, Kaplan KL. 1985. The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations. Medicine 64:192-202 (Pubitemid 15041541)
51. Utz JP, Ryu JH, Myers JL, Michels VV. 2005. Usual interstitial pneumonia complicating dyskeratosis congenita. Mayo Clin. Proc. 80:817-21 (Pubitemid 40770371)
52. Allen M, Heinzmann A, Noguchi E, Abecasis G, Broxholme J, et al. 2003. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat. Genet. 35:258-63 (Pubitemid 37363180)
53. Laitinen T, Polvi A, Rydman P, Vendelin J, Pulkkinen V, et al. 2004. Characterization of a common susceptibility locus for asthma-related traits. Science 304:300-4 (Pubitemid 38452184)
54. Nicolae D, Cox NJ, Lester LA, Schneider D, Tan Z, et al. 2005. Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am. J. Hum. Genet. 76:349-57 (Pubitemid 40129561)
55. Noguchi E, Yokouchi Y, Zhang J, Shibuya K, Shibuya A, et al. 2005. Positional identification of an asthma susceptibility gene on human chromosome 5q33. Am. J. Respir. Crit. CareMed. 172:183-88 (Pubitemid 40981191)
56. Oguma T, Palmer LJ, Birben E, Sonna LA, Asano K, Lilly CM. 2004. Role of prostanoid DP receptor variants in susceptibility to asthma. N. Engl. J. Med. 351:1752-63 (Pubitemid 39383210)
57. Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, et al. 2002. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418:426-30 (Pubitemid 34826843)
58. Zhang Y, Leaves NI, Anderson GG, Ponting CP, Broxholme J, et al. 2003. Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma. Nat. Genet. 34:181-86 (Pubitemid 36666929)
59. Ober C, Hoffjan S. 2006. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun. 7:95-100 (Pubitemid 43336051)
60. Silverman EK, Mosley JD, Palmer LJ, Barth M, Senter JM, et al. 2002. Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. Hum. Mol. Genet. 11:623-32 (Pubitemid 34285133)
61. Hodgson U, Pulkkinen V, Dixon M, Peyrard-Janvid M, Rehn M, et al. 2006. ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis. Am. J. Hum. Genet. 79:149-54 (Pubitemid 43927386)
62. Vercelli D. 2008. Discovering susceptibility genes for asthma and allergy. Nat. Rev. Immunol. 8:169-82 (Pubitemid 351323288)
63. Lomas DA, Silverman EK. 2001. The genetics of chronic obstructive pulmonary disease. Respir. Res. 2:20-26 (Pubitemid 34187903)
64. Demeo DL, Sandhaus RA, Barker AF, Brantly ML, Eden E, et al. 2007. Determinants of airflow obstruction in severe α-1-antitrypsin deficiency. Thorax 62:806-13
65. CooksonWO. 2006. State of the art. Genetics and genomics of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 3:473-75 (Pubitemid 44285517)
66. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, et al. 2007. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356:1317-26 (Pubitemid 46513297)
67. Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, et al. 2007. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl. Acad. Sci. USA 104:7552-57 (Pubitemid 47185944)
68. Nogee LM, Dunbar AE 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA. 2001. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 344:573-79 (Pubitemid 32167871)
69. Thomas AQ, Lane K, Phillips J 3rd, Prince M, Markin C, et al. 2002. Heterozygosity for a surfactant proteinCgene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am. J. Respir. Crit. Care Med. 165:1322-28 (Pubitemid 34461748)
70. Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, et al. 2009. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am. J. Hum. Genet. 84:52-59
71. Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan D, et al. 2007. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448:470-73 (Pubitemid 47123521)
72. Flory JH, Sleiman PM, Christie JD, Annaiah K, Bradfield J, et al. 2009. 17q12-21 variants interact with smoke exposure as a risk factor for pediatric asthma but are equally associated with early-onset versus late-onset asthma in North Americans of European ancestry. J. Allergy Clin. Immunol. 124:605-7
73. Galanter J, Choudhry S, Eng C, Nazario S, Rodriguez-Santana JR, et al. 2008. ORMDL3 gene is associated with asthma in three ethnically diverse populations. Am. J. Respir. Crit. Care Med. 177:1194-200 (Pubitemid 351860927)
74. Halapi E, Gudbjartsson DF, Jonsdottir GM, Bjornsdottir US, Thorleifsson G, et al. 2010. A sequence variant on 17q21 is associated with age at onset and severity of asthma. Eur. J. Hum. Genet. 18:902-8
75. Hirota T, Harada M, Sakashita M, Doi S, Miyatake A, et al. 2008. Genetic polymorphism regulating ORM1-like 3 (Saccharomyces cerevisiae) expression is associated with childhood atopic asthma in a Japanese population. J. Allergy Clin. Immunol. 121:769-70
76. Leung TF, Sy HY, Ng MC, Chan IH, Wong GW, et al. 2009. Asthma and atopy are associated with chromosome 17q21 markers in Chinese children. Allergy 64:621-28
77. Cantero-Recasens G, Fandos C, Rubio-Moscardo F, Valverde MA, Vicente R. 2010. The asthmaassociated ORMDL3 gene product regulates endoplasmic reticulum-mediated calcium signaling and cellular stress. Hum. Mol. Genet. 19:111-21
78. Verlaan DJ, Berlivet S, Hunninghake GM, Madore AM, Lariviere M, et al. 2009. Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. Am. J. Hum. Genet. 85:377-93
79. Himes BE, Hunninghake GM, Baurley JW, Rafaels NM, Sleiman P, et al. 2009. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am. J. Hum. Genet. 84:581-93
80. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, et al. 2009. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 5:e1000421
81. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, et al. 2008. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 40:616-22 (Pubitemid 351601203)
82. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, et al. 2008. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452:633-37 (Pubitemid 351483367)
83. ChoMH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, et al. 2010. Variants inFAM13Aare associated with chronic obstructive pulmonary disease. Nat. Genet. 42:200-2
84. HancockDB, EijgelsheimM, Wilk JB, Gharib SA, Loehr LR, et al. 2010. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat. Genet. 42:45-52
85. Choudhry S, Coyle NE, Tang H, Salari K, Lind D, et al. 2006. Population stratification confounds genetic association studies among Latinos. Hum. Genet. 118:652-64 (Pubitemid 41825137)
86. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, et al. 1998. Estimating African American admixture proportions by use of population-specific alleles. Am. J. Hum. Genet. 63:1839-51 (Pubitemid 30415746)
87. Choudhry S, Seibold MA, Borrell LN, Tang H, Serebrisky D, et al. 2007. Dissecting complex diseases in complex populations: asthma in Latino Americans. Proc. Am. Thorac. Soc. 4:226-33 (Pubitemid 47036440)
88. Kelley CF, Mannino DM, Homa DM, Savage-Brown A, Holguin F. 2005. Asthma phenotypes, risk factors, and measures of severity in a national sample of US children. Pediatrics 115:726-31 (Pubitemid 43373035)
89. Mannino DM, Gagnon RC, Petty TL, Lydick E. 2000. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988 Arch. Intern. Med. 160:1683-89 (Pubitemid 30367908)
90. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. 2002. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill. Summ. 51:1-16
91. Dransfield MT, Davis JJ, Gerald LB, Bailey WC. 2006. Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. Respir.Med. 100:1110-16
92. Perez-Stable EJ, Herrera B, Jacob P 3rd, Benowitz NL. 1998. Nicotine metabolism and intake in black and white smokers. JAMA 280:152-56 (Pubitemid 28498387)
93. Harik-Khan RI, Fleg JL, Muller DC, Wise RA. 2001. The effect of anthropometric and socioeconomic factors on the racial difference in lung function. Am. J. Respir. Crit. Care Med. 164:1647-54 (Pubitemid 33124153)
94. Harik-Khan RI, Muller DC, Wise RA. 2004. Racial difference in lung function in African-American and White children: effect of anthropometric, socioeconomic, nutritional, and environmental factors. Am. J. Epidemiol. 160:893-900 (Pubitemid 39434773)
95. Salari K, Choudhry S, Tang H, Naqvi M, Lind D, et al. 2005. Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmatics. Genet. Epidemiol. 29:76-86 (Pubitemid 40911301)
96. Kumar R, Seibold MA, Aldrich MC, Williams LK, Reiner AP, et al. 2010. Genetic ancestry in lungfunction predictions. N. Engl. J. Med. 363:321-30
97. Smith MW, Lautenberger JA, Shin HD, Chretien JP, Shrestha S, et al. 2001. Markers for mapping by admixture linkage disequilibrium in African American and Hispanic populations. Am. J. Hum. Genet. 69:1080-94 (Pubitemid 33015823)
98. Winkler CA, Nelson GW, Smith MW. 2010. Admixture mapping comes of age. Annu. Rev. Genomics Hum. Genet. 11:65-89
99. McKeigue PM. 1997. Mapping genes underlying ethnic differences in disease risk by linkage disequilibrium in recently admixed populations. Am. J. Hum. Genet. 60:188-96 (Pubitemid 26427793)
100. Stephens JC, Briscoe D, O'Brien SJ. 1994. Mapping by admixture linkage disequilibrium in human populations: limits and guidelines. Am. J. Hum. Genet. 55:809-24 (Pubitemid 24298979)
101. Bock CH, Schwartz AG, Ruterbusch JJ, Levin AM, Neslund-Dudas C, et al. 2009. Results from a prostate cancer admixture mapping study in African-American men. Hum. Genet. 126:637-42
102. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, et al. 2006. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc. Natl. Acad. Sci. USA 103:14068-73 (Pubitemid 44452981)
103. Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, et al. 2007. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am. J. Hum. Genet. 80:716-26 (Pubitemid 46564408)
104. Reich D, Nalls MA, Kao WH, Akylbekova EL, Tandon A, et al. 2009. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet. 5:e1000360
105. Zhu X, Luke A, Cooper RS, Quertermous T, Hanis C, et al. 2005. Admixture mapping for hypertension loci with genome-scan markers. Nat. Genet. 37:177-81
106. DeMeo DL, Campbell EJ, Brantly ML, Barker AF, Eden E, et al. 2009. Heritability of lung function in severe α-1 antitrypsin deficiency. Hum. Hered. 67:38-45
107. Silverman EK, Pierce JA, Province MA, Rao DC, Campbell EJ. 1989. Variability of pulmonary function in α-1-antitrypsin deficiency: clinical correlates. Ann. Intern. Med. 111:982-91 (Pubitemid 20034922)
108. Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ. 2009. Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Eur. Respir. J. 33:468-80
109. Polonikov AV, Ivanov VP, Solodilova MA. 2009. Genetic variation of genes for xenobiotic-metabolizing enzymes and risk of bronchial asthma: the importance of gene-gene and gene-environment interactions for disease susceptibility. J. Hum. Genet. 54:440-49
110. Martinez FD. 2007. CD14, endotoxin, and asthma risk: actions and interactions. Proc. Am. Thorac. Soc. 4:221-25 (Pubitemid 47036439)
111. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. 1999. A polymorphism- in the 5- flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell Mol. Biol. 20:976-83
112. Kedda MA, Lose F, Duffy D, Bell E, Thompson PJ, Upham J. 2005. The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population. Thorax 60:211-14 (Pubitemid 40380279)
113. Koppelman GH, Reijmerink NE, Stine OC, Howard TD, Whittaker PA, et al. 2001. Association of a promoter polymorphism of the CD14 gene and atopy. Am. J. Respir. Crit. CareMed. 163:965-69 (Pubitemid 32275872)
114. Ober C, Tsalenko A, Parry R, Cox NJ. 2000. A second-generation genomewide screen for asthmasusceptibility alleles in a founder population. Am. J. Hum. Genet. 67:1154-62
115. Eder W, Klimecki W, Yu L, von Mutius E, Riedler J, et al. 2005. Opposite effects of CD 14/-260 on serum IgE levels in children raised in different environments. J. Allergy Clin. Immunol. 116:601-7 (Pubitemid 41267134)
116. Simpson A, John SL, Jury F, Niven R, Woodcock A, et al. 2006. Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. Am. J. Respir. Crit. Care Med. 174:386-92 (Pubitemid 44223118)
117. Williams LK, McPhee RA, Ownby DR, Peterson EL, James M, et al. 2006. Gene-environment interactions with CD14 C-260T and their relationship to total serum IgE levels in adults. J. Allergy Clin. Immunol. 118:851-57 (Pubitemid 44498756)
118. Zambelli-Weiner A, Ehrlich E, Stockton ML, Grant AV, Zhang S, et al. 2005. Evaluation of the CD14/-260 polymorphism and house dust endotoxin exposure in the Barbados Asthma Genetics Study. J. Allergy Clin. Immunol. 115:1203-9 (Pubitemid 40824590)
119. Martinez FD. 2007. Gene-environment interactions in asthma: with apologies to William of Ockham. Proc. Am. Thorac. Soc. 4(1):26-31 (Pubitemid 46067559)
120. Roth TL, Sweatt JD. 2009. Regulation of chromatin structure in memory formation. Curr. Opin. Neurobiol. 19(3):336-42
121. Dolinoy DC. 2008. The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome. Nutr. Rev. 66(Suppl. 1):7-11
122. Waterland RA, Jirtle RL. 2003. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol. 23:5293-300 (Pubitemid 36950884)
123. Schwartz DA. 2010. Epigenetics and environmental lung disease. Proc. Am. Thorac. Soc. 7:123-25
124. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, et al. 2005. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N. Engl. J. Med. 352:1967-76 (Pubitemid 40638367)
125. Ito K, Lim S, Caramori G, Cosio B, Chung KF, et al. 2002. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc. Natl. Acad. Sci. USA 99:8921-26 (Pubitemid 34693659)
126. Weiss ST, Raby BA, Rogers A. 2009. Asthma genetics and genomics 2009. Curr. Opin. Genet. Dev. 19:279-82
127. Manolio TA, Collins FS, CoxNJ, GoldsteinDB, Hindorff LA, et al. 2009. Finding the missing heritability of complex diseases. Nature 461:747-53
128. Weedon MN, Lango H, Lindgren CM, Wallace C, Evans DM, et al. 2008. Genome-wide association analysis identifies 20 loci that influence adult height. Nat. Genet. 40:575-83 (Pubitemid 351601210)
129. Tucker T, Marra M, Friedman JM. 2009. Massively parallel sequencing: the next big thing in genetic medicine. Am. J. Hum. Genet. 85:142-54
130. Mardis ER. 2008. Next-generation DNA sequencing methods. Annu. Rev. Genomics Hum. Genet. 9:387-402
131. Nejentsev S, Walker N, Riches D, EgholmM, Todd JA. 2009. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324:387-89
132. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, et al. 2009. Targeted capture andmassively parallel sequencing of 12 human exomes. Nature 461:272-76
133. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, et al. 2010. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 42:30-35